Sign Up And Receive Our Latest Promotions!
.svg){kind=small}
Our latest
Press Releases & Updates
Latest press releases
RetinAI OCT Atlas® is now CE-marked for Clinical Use: one algorithm for AMD, DR, DME, and Glaucoma
.png)
RetinAI & OptymEdge Collaborate to Accelerate Ophthalmic Drug Development Through AI-Powered Reading Center Solutions
EarlySight announces strategic collaboration with RetinAI to enhance clinical Insights from its Cellularis® Retinal Imaging Platform
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
Latest updates
Swiss AI Day: Empower your business [JUNE'17]
RetinAI will be participating in the Swiss AI Day: EmPOWER your Business, taking place on June 14th in Bern, and featuring top speakers in finance, insurance, healthcare, life sciences and research in AI. Don't miss the date and register now!
Ready for MICCA! [MAY'17]
RetinAI + UniBern's collaboration on Optical Coherence Tomography (OCT) has outcome in a publication in the prestigious conference MICCAI'2017. Meet the RetinAI team in Quebec this September and have some discussions about Machine Learning in Ophthalmology.
ARVO 2017, Baltimore [MAY'17]
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analysis and Fundus Imaging.
Contact us for more informations! We are happy to hear from you!
Ikerian AG (HQ)
Freiburgstrasse 3
3010 Bern
Switzerland
RetinAI US Inc. (US)
6 Liberty Square
#2498 Boston, MA 02109
United States
Imprint/Legal Notice | Data Processing Agreement | Privacy Notice | Created by Ikerian AG. All rights reserved 2016-2026 ©